CCC Diagnostics Inc Announces Expanded Insurance Coverage for the DirectHit Panel for Breast Cancer
CCC Diagnostics Inc has received expanded insurance coverage for the DirectHit Panel for Breast cancer. This expanded coverage includes CareFirst BlueCross/Blue Shield, WellPoint Unicare Networks, CMS Highmark Medicare Services and AmeriGroup. - February 04, 2011
CCC Diagnostics, Inc Awarded Qualifying Therapeutic Discovery Project Grant
CCC Diagnostics Inc. has been awarded a Qualifying Therapeutic Discovery Project grant. This grant was awarded to further development and commercialization of the DirectHitTM Test Panel for Breast Cancer. DirectHit is a vastly improved diagnostic test for breast cancer treatment that accurately predicts the tumor’s response to four commonly prescribed classes of anti-cancer drugs. - January 21, 2011
CCC Diagnostis Inc. Launches Improved Test for Breast Cancer Treatment
CCC Diagnostics Inc has released the DirectHit Panel for Breast Cancer. DirectHit is a CLIA certified test, that accurately predicts the tumor’s response to four commonly prescribed classes of anti-cancer drugs. DirectHit allows a physician to personalize treatment plans for breast cancer patients. - January 12, 2011